

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 6.04132940 |
| 2 | collagen fibril organization (GO:0030199) | 5.82216864 |
| 3 | wound healing, spreading of epidermal cells (GO:0035313) | 5.28212329 |
| 4 | virion attachment to host cell (GO:0019062) | 4.67509535 |
| 5 | adhesion of symbiont to host cell (GO:0044650) | 4.67509535 |
| 6 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.55392855 |
| 7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.49054940 |
| 8 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.48270109 |
| 9 | cellular response to interferon-alpha (GO:0035457) | 4.42646465 |
| 10 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.40540933 |
| 11 | skin morphogenesis (GO:0043589) | 4.37859866 |
| 12 | endodermal cell differentiation (GO:0035987) | 4.36004026 |
| 13 | bone trabecula formation (GO:0060346) | 4.30352687 |
| 14 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.21773963 |
| 15 | regulation of chronic inflammatory response (GO:0002676) | 4.11461890 |
| 16 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.09215493 |
| 17 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.08178846 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.08113147 |
| 19 | adhesion of symbiont to host (GO:0044406) | 4.04276076 |
| 20 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.04009495 |
| 21 | wound healing, spreading of cells (GO:0044319) | 3.94746270 |
| 22 | regulation of vitamin metabolic process (GO:0030656) | 3.94525225 |
| 23 | regulation of mononuclear cell migration (GO:0071675) | 3.82831943 |
| 24 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.75701258 |
| 25 | collagen metabolic process (GO:0032963) | 3.73849223 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.73465409 |
| 27 | chondrocyte proliferation (GO:0035988) | 3.72843415 |
| 28 | collagen catabolic process (GO:0030574) | 3.71009240 |
| 29 | cell adhesion mediated by integrin (GO:0033627) | 3.70229624 |
| 30 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.52220894 |
| 31 | regulation of chemokine biosynthetic process (GO:0045073) | 3.49875840 |
| 32 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.48699523 |
| 33 | apoptotic cell clearance (GO:0043277) | 3.46334053 |
| 34 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.45246659 |
| 35 | eosinophil chemotaxis (GO:0048245) | 3.43109566 |
| 36 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.43008877 |
| 37 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.41693831 |
| 38 | peptidyl-proline hydroxylation (GO:0019511) | 3.40989374 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38798664 |
| 40 | regulation of fever generation (GO:0031620) | 3.38076434 |
| 41 | multicellular organismal catabolic process (GO:0044243) | 3.35591104 |
| 42 | positive regulation of heat generation (GO:0031652) | 3.34910855 |
| 43 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.29009305 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.28312200 |
| 45 | extracellular matrix assembly (GO:0085029) | 3.27203597 |
| 46 | chronic inflammatory response (GO:0002544) | 3.26914279 |
| 47 | dermatan sulfate biosynthetic process (GO:0030208) | 3.26536849 |
| 48 | multicellular organismal metabolic process (GO:0044236) | 3.25951713 |
| 49 | axon extension involved in axon guidance (GO:0048846) | 3.24770711 |
| 50 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.24770711 |
| 51 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.23068722 |
| 52 | cell migration involved in heart development (GO:0060973) | 3.21821922 |
| 53 | regulation of monocyte chemotaxis (GO:0090025) | 3.21516538 |
| 54 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.17196413 |
| 55 | epoxygenase P450 pathway (GO:0019373) | 3.17057333 |
| 56 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.16992634 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16811936 |
| 58 | blood vessel maturation (GO:0001955) | 3.16104519 |
| 59 | response to interferon-alpha (GO:0035455) | 3.15696742 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.15618131 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.15618131 |
| 62 | endothelial cell morphogenesis (GO:0001886) | 3.10535497 |
| 63 | positive regulation of astrocyte differentiation (GO:0048711) | 3.10523292 |
| 64 | response to type I interferon (GO:0034340) | 3.09966130 |
| 65 | tooth mineralization (GO:0034505) | 3.09942236 |
| 66 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.07989060 |
| 67 | fibril organization (GO:0097435) | 3.07942957 |
| 68 | extracellular matrix disassembly (GO:0022617) | 3.05532169 |
| 69 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.03838663 |
| 70 | eosinophil migration (GO:0072677) | 3.01844854 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.01427646 |
| 72 | response to peptidoglycan (GO:0032494) | 3.01169338 |
| 73 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00887680 |
| 74 | extracellular fibril organization (GO:0043206) | 2.99027757 |
| 75 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.98832971 |
| 76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98364337 |
| 77 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.98125347 |
| 78 | hyaluronan catabolic process (GO:0030214) | 2.95940545 |
| 79 | cellular response to vitamin (GO:0071295) | 2.95882369 |
| 80 | dermatan sulfate metabolic process (GO:0030205) | 2.94590175 |
| 81 | cellular response to amino acid stimulus (GO:0071230) | 2.94088510 |
| 82 | regulation of plasminogen activation (GO:0010755) | 2.93179139 |
| 83 | omega-hydroxylase P450 pathway (GO:0097267) | 2.92239297 |
| 84 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.92218239 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90650889 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 2.90650889 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90650889 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90650889 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90650889 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 2.90650889 |
| 91 | regulation of immunoglobulin secretion (GO:0051023) | 2.90643756 |
| 92 | protein localization to endosome (GO:0036010) | 2.90352043 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.89766859 |
| 94 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.89149236 |
| 95 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.89067177 |
| 96 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.89034673 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88565354 |
| 98 | cellular response to vitamin D (GO:0071305) | 2.87477733 |
| 99 | keratan sulfate catabolic process (GO:0042340) | 2.87335722 |
| 100 | regulation of heat generation (GO:0031650) | 2.86734404 |
| 101 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.85966691 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.85403652 |
| 103 | negative regulation of biomineral tissue development (GO:0070168) | 2.84979473 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82619292 |
| 105 | removal of superoxide radicals (GO:0019430) | 2.78733641 |
| 106 | cellular response to superoxide (GO:0071451) | 2.78733641 |
| 107 | cellular response to oxygen radical (GO:0071450) | 2.78733641 |
| 108 | positive regulation of extracellular matrix organization (GO:1903055) | 2.76548912 |
| 109 | negative regulation of lipid storage (GO:0010888) | 2.75277015 |
| 110 | respiratory burst (GO:0045730) | 2.73902214 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73360025 |
| 112 | monocyte chemotaxis (GO:0002548) | 2.73068850 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.72870196 |
| 114 | positive regulation of chemokine production (GO:0032722) | 2.71924243 |
| 115 | regulation of interferon-alpha production (GO:0032647) | 2.71889937 |
| 116 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.71868859 |
| 117 | superoxide anion generation (GO:0042554) | 2.71574010 |
| 118 | response to muramyl dipeptide (GO:0032495) | 2.68863323 |
| 119 | response to magnesium ion (GO:0032026) | 2.68593078 |
| 120 | decidualization (GO:0046697) | 2.68420923 |
| 121 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.68131970 |
| 122 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.67283906 |
| 123 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.67159033 |
| 124 | substrate-dependent cell migration (GO:0006929) | 2.66900207 |
| 125 | negative regulation of monooxygenase activity (GO:0032769) | 2.65401400 |
| 126 | barbed-end actin filament capping (GO:0051016) | 2.64926693 |
| 127 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.64556988 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63390173 |
| 129 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.62964389 |
| 130 | cellular response to lipopolysaccharide (GO:0071222) | 2.62788044 |
| 131 | activation of MAPKKK activity (GO:0000185) | 2.62271783 |
| 132 | regulation of extracellular matrix disassembly (GO:0010715) | 2.59948278 |
| 133 | positive regulation of acute inflammatory response (GO:0002675) | 2.58843121 |
| 134 | type B pancreatic cell proliferation (GO:0044342) | 2.58636198 |
| 135 | reactive oxygen species biosynthetic process (GO:1903409) | 2.57901486 |
| 136 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.56775688 |
| 137 | negative regulation of fatty acid transport (GO:2000192) | 2.55024491 |
| 138 | metanephric mesenchyme development (GO:0072075) | 2.54976538 |
| 139 | kidney mesenchyme development (GO:0072074) | 2.54886142 |
| 140 | regulation of podosome assembly (GO:0071801) | 2.54350857 |
| 141 | negative regulation of platelet activation (GO:0010544) | 2.54025522 |
| 142 | protein hydroxylation (GO:0018126) | 2.53012950 |
| 143 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.52849593 |
| 144 | positive regulation of interleukin-6 production (GO:0032755) | 2.52498226 |
| 145 | positive regulation of fibroblast migration (GO:0010763) | 2.52486028 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.52482320 |
| 147 | positive regulation of p38MAPK cascade (GO:1900745) | 2.51320276 |
| 148 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.51310203 |
| 149 | regulation of macrophage cytokine production (GO:0010935) | 2.51286703 |
| 150 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.51236770 |
| 151 | negative regulation of cytokine secretion (GO:0050710) | 2.50101668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.85275323 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.92799665 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56247470 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21758130 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.05614195 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.85077600 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.43568323 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.27638589 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13846901 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08963237 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.05724557 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92708446 |
| 13 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.85812612 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.82476001 |
| 15 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.80837439 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72614950 |
| 17 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.58753367 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57519981 |
| 19 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.54172078 |
| 20 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.54172078 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 2.48393733 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36195117 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.29637715 |
| 24 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.25455813 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23225287 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22401846 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.08144871 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04477205 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.00864954 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00722314 |
| 31 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.83758729 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82884521 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72188085 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.69956751 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66762852 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66582222 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64835147 |
| 38 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58812504 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.58649918 |
| 40 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.58649918 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.53801021 |
| 42 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52546561 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50465370 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50149728 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49665884 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47771063 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45433783 |
| 48 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.43705332 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43111996 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37606421 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37483058 |
| 52 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.36463786 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33393501 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30991713 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30937357 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29345993 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25179096 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24444906 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22221255 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19912100 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17693099 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15157661 |
| 63 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14871466 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13810448 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12438931 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09511036 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09472198 |
| 68 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09307269 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07391944 |
| 70 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04755015 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03352248 |
| 72 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02975484 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02800193 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02293389 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01748812 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01748812 |
| 77 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00821315 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00537435 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99905186 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99681387 |
| 81 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99614033 |
| 82 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99066634 |
| 83 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99066634 |
| 84 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99066634 |
| 85 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98920134 |
| 86 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96859931 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95734706 |
| 88 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.92920438 |
| 89 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.92735039 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92152354 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91772047 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91127009 |
| 93 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90363343 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90202522 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89285710 |
| 96 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89181525 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88494504 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87970205 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85449559 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85433323 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84803468 |
| 102 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83965307 |
| 103 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83041174 |
| 104 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82632371 |
| 105 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81853173 |
| 106 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81561446 |
| 107 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.80437539 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80040013 |
| 109 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79120769 |
| 110 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78172746 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77157279 |
| 112 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76982338 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76516094 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75685733 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74108337 |
| 116 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.72523527 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72343391 |
| 118 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69919492 |
| 119 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69919492 |
| 120 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.69817350 |
| 121 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.69632522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 8.68855824 |
| 2 | MP0005275_abnormal_skin_tensile | 5.44513726 |
| 3 | MP0005503_abnormal_tendon_morphology | 5.33950382 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 4.72096859 |
| 5 | MP0003279_aneurysm | 4.43944118 |
| 6 | MP0001958_emphysema | 3.66327894 |
| 7 | MP0009384_cardiac_valve_regurgitation | 2.89713641 |
| 8 | MP0003724_increased_susceptibility_to | 2.53182852 |
| 9 | MP0006054_spinal_hemorrhage | 2.44732584 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.40277524 |
| 11 | MP0003436_decreased_susceptibility_to | 2.17988252 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.08169360 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.02131800 |
| 14 | MP0002295_abnormal_pulmonary_circulatio | 2.01773119 |
| 15 | MP0001542_abnormal_bone_strength | 1.97052198 |
| 16 | MP0002933_joint_inflammation | 1.96667024 |
| 17 | MP0005508_abnormal_skeleton_morphology | 1.85389172 |
| 18 | MP0005390_skeleton_phenotype | 1.83101565 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 1.80114228 |
| 20 | MP0006082_CNS_inflammation | 1.78575662 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.73168733 |
| 22 | MP0002060_abnormal_skin_morphology | 1.70015809 |
| 23 | MP0003303_peritoneal_inflammation | 1.69223871 |
| 24 | MP0002998_abnormal_bone_remodeling | 1.69214340 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.68729576 |
| 26 | MP0005171_absent_coat_pigmentation | 1.64218253 |
| 27 | MP0005023_abnormal_wound_healing | 1.63587945 |
| 28 | MP0009785_altered_susceptibility_to | 1.61796048 |
| 29 | MP0004272_abnormal_basement_membrane | 1.55937010 |
| 30 | MP0004858_abnormal_nervous_system | 1.51016491 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.48560326 |
| 32 | MP0003448_altered_tumor_morphology | 1.46304663 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.45413729 |
| 34 | MP0003091_abnormal_cell_migration | 1.43220047 |
| 35 | MP0002254_reproductive_system_inflammat | 1.39007851 |
| 36 | MP0009840_abnormal_foam_cell | 1.38830659 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.37337440 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.37047975 |
| 39 | * MP0002419_abnormal_innate_immunity | 1.34950183 |
| 40 | MP0001243_abnormal_dermal_layer | 1.34917807 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.34404348 |
| 42 | MP0003941_abnormal_skin_development | 1.25265278 |
| 43 | MP0003385_abnormal_body_wall | 1.18007779 |
| 44 | MP0000767_abnormal_smooth_muscle | 1.17237306 |
| 45 | MP0009764_decreased_sensitivity_to | 1.13433094 |
| 46 | MP0002282_abnormal_trachea_morphology | 1.12136535 |
| 47 | MP0002896_abnormal_bone_mineralization | 1.11995893 |
| 48 | MP0005165_increased_susceptibility_to | 1.11274351 |
| 49 | MP0005164_abnormal_response_to | 1.10532338 |
| 50 | MP0000858_altered_metastatic_potential | 1.09177251 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.08495738 |
| 52 | MP0000343_altered_response_to | 1.06960621 |
| 53 | MP0000604_amyloidosis | 1.05807495 |
| 54 | MP0009250_abnormal_appendicular_skeleto | 1.05794708 |
| 55 | MP0002115_abnormal_skeleton_extremities | 1.05104246 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.05103462 |
| 57 | MP0005451_abnormal_body_composition | 1.05035543 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.04473868 |
| 59 | MP0004947_skin_inflammation | 1.03775657 |
| 60 | MP0004134_abnormal_chest_morphology | 1.02708493 |
| 61 | * MP0005025_abnormal_response_to | 0.99830606 |
| 62 | MP0009278_abnormal_bone_marrow | 0.98545367 |
| 63 | MP0003795_abnormal_bone_structure | 0.97163013 |
| 64 | MP0000163_abnormal_cartilage_morphology | 0.94102584 |
| 65 | MP0004510_myositis | 0.93871832 |
| 66 | MP0000733_abnormal_muscle_development | 0.90682442 |
| 67 | MP0000685_abnormal_immune_system | 0.90329598 |
| 68 | MP0002168_other_aberrant_phenotype | 0.88968773 |
| 69 | MP0001853_heart_inflammation | 0.88634671 |
| 70 | * MP0002452_abnormal_antigen_presenting | 0.87785366 |
| 71 | MP0002113_abnormal_skeleton_development | 0.87127548 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 0.86372808 |
| 73 | MP0003075_altered_response_to | 0.85502391 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.82609009 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.82609009 |
| 76 | MP0008469_abnormal_protein_level | 0.82083733 |
| 77 | MP0008004_abnormal_stomach_pH | 0.81651899 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.81625927 |
| 79 | MP0002133_abnormal_respiratory_system | 0.76920634 |
| 80 | MP0005388_respiratory_system_phenotype | 0.76920634 |
| 81 | MP0005197_abnormal_uvea_morphology | 0.76109050 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.75156560 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.74324897 |
| 84 | MP0001790_abnormal_immune_system | 0.74231566 |
| 85 | MP0005387_immune_system_phenotype | 0.74231566 |
| 86 | MP0002006_tumorigenesis | 0.73729941 |
| 87 | MP0004233_abnormal_muscle_weight | 0.71372856 |
| 88 | MP0002723_abnormal_immune_serum | 0.71156233 |
| 89 | MP0009763_increased_sensitivity_to | 0.69172368 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.68932031 |
| 91 | * MP0002405_respiratory_system_inflammati | 0.68642302 |
| 92 | MP0003045_fibrosis | 0.68398059 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.66200756 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.65729298 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.64863213 |
| 96 | MP0001915_intracranial_hemorrhage | 0.64385421 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.64197485 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.63268803 |
| 99 | MP0005166_decreased_susceptibility_to | 0.63013987 |
| 100 | MP0000249_abnormal_blood_vessel | 0.61907200 |
| 101 | MP0009053_abnormal_anal_canal | 0.61718396 |
| 102 | MP0001849_ear_inflammation | 0.61474243 |
| 103 | MP0002932_abnormal_joint_morphology | 0.60928748 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.60783310 |
| 105 | MP0001851_eye_inflammation | 0.60698412 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.60215387 |
| 107 | MP0010030_abnormal_orbit_morphology | 0.60004761 |
| 108 | MP0000751_myopathy | 0.58952370 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.58765157 |
| 110 | MP0001614_abnormal_blood_vessel | 0.58763409 |
| 111 | MP0003828_pulmonary_edema | 0.57586425 |
| 112 | MP0001879_abnormal_lymphatic_vessel | 0.57175782 |
| 113 | MP0005671_abnormal_response_to | 0.56993839 |
| 114 | MP0002128_abnormal_blood_circulation | 0.56522760 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.56377280 |
| 116 | MP0000428_abnormal_craniofacial_morphol | 0.56212295 |
| 117 | * MP0001819_abnormal_immune_cell | 0.54318231 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.53944443 |
| 119 | MP0001177_atelectasis | 0.53235269 |
| 120 | MP0004883_abnormal_blood_vessel | 0.52715933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 9.10399217 |
| 2 | Premature rupture of membranes (HP:0001788) | 8.41868063 |
| 3 | Peritonitis (HP:0002586) | 6.75502079 |
| 4 | Soft skin (HP:0000977) | 5.28041529 |
| 5 | Aortic dissection (HP:0002647) | 5.06373749 |
| 6 | Vertebral compression fractures (HP:0002953) | 4.82731441 |
| 7 | Dilatation of the ascending aorta (HP:0005111) | 4.37049740 |
| 8 | Atrophic scars (HP:0001075) | 4.36654959 |
| 9 | Bladder diverticulum (HP:0000015) | 4.31230690 |
| 10 | Aortic aneurysm (HP:0004942) | 4.19524911 |
| 11 | Genu recurvatum (HP:0002816) | 4.19066303 |
| 12 | Shallow orbits (HP:0000586) | 4.18250755 |
| 13 | Abnormality of dentin (HP:0010299) | 4.16707150 |
| 14 | Biconcave vertebral bodies (HP:0004586) | 4.13472063 |
| 15 | Ankle contracture (HP:0006466) | 4.04983578 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.99205159 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.99205159 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.99205159 |
| 19 | Wormian bones (HP:0002645) | 3.73340898 |
| 20 | Fragile skin (HP:0001030) | 3.67226670 |
| 21 | Neonatal short-limb short stature (HP:0008921) | 3.61405897 |
| 22 | Vascular tortuosity (HP:0004948) | 3.54209670 |
| 23 | Wrist flexion contracture (HP:0001239) | 3.45650596 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.44711792 |
| 25 | Broad metatarsal (HP:0001783) | 3.40841510 |
| 26 | Blue sclerae (HP:0000592) | 3.38803289 |
| 27 | Arterial tortuosity (HP:0005116) | 3.22822982 |
| 28 | Mitral valve prolapse (HP:0001634) | 3.21135042 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.19962548 |
| 30 | Overgrowth (HP:0001548) | 3.15722850 |
| 31 | Abnormal delivery (HP:0001787) | 3.06729875 |
| 32 | Hyperextensible skin (HP:0000974) | 3.04481044 |
| 33 | Abnormality of the peritoneum (HP:0002585) | 3.03723282 |
| 34 | Cervical subluxation (HP:0003308) | 3.03210891 |
| 35 | Bowel diverticulosis (HP:0005222) | 2.97242327 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.97215919 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.96449997 |
| 38 | Infantile muscular hypotonia (HP:0008947) | 2.90684382 |
| 39 | Nuclear cataract (HP:0100018) | 2.84094513 |
| 40 | Coxa vara (HP:0002812) | 2.83146830 |
| 41 | Ectopia lentis (HP:0001083) | 2.80366686 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.79762789 |
| 43 | Orchitis (HP:0100796) | 2.74899608 |
| 44 | Spondylolisthesis (HP:0003302) | 2.63272554 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62757118 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59620303 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59620303 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59620303 |
| 49 | Breech presentation (HP:0001623) | 2.59089829 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.58079174 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.57919002 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57919002 |
| 53 | Elbow flexion contracture (HP:0002987) | 2.57409187 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55063756 |
| 55 | Hematochezia (HP:0002573) | 2.53930719 |
| 56 | Osteoarthritis (HP:0002758) | 2.51802944 |
| 57 | Spinal rigidity (HP:0003306) | 2.51058344 |
| 58 | Slender build (HP:0001533) | 2.48521417 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47788973 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.47788973 |
| 61 | Optic neuritis (HP:0100653) | 2.47700598 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.47700598 |
| 63 | Abnormality of the acetabulum (HP:0003170) | 2.46730882 |
| 64 | Aortic valve stenosis (HP:0001650) | 2.45692112 |
| 65 | Broad ribs (HP:0000885) | 2.43910718 |
| 66 | Ovoid vertebral bodies (HP:0003300) | 2.43012995 |
| 67 | Mitral stenosis (HP:0001718) | 2.40533858 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.40416343 |
| 69 | Joint stiffness (HP:0001387) | 2.38921075 |
| 70 | Thin bony cortex (HP:0002753) | 2.38229680 |
| 71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.33497192 |
| 72 | Tibial bowing (HP:0002982) | 2.32617384 |
| 73 | Aneurysm (HP:0002617) | 2.25486698 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.25478768 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.24687449 |
| 76 | Nonimmune hydrops fetalis (HP:0001790) | 2.22061109 |
| 77 | Myositis (HP:0100614) | 2.20966079 |
| 78 | Joint laxity (HP:0001388) | 2.19822406 |
| 79 | Flared iliac wings (HP:0002869) | 2.19343207 |
| 80 | Femoral bowing (HP:0002980) | 2.13354207 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 2.12661689 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.10186572 |
| 83 | Coronal craniosynostosis (HP:0004440) | 2.08231594 |
| 84 | Limited elbow extension (HP:0001377) | 2.06258665 |
| 85 | Deviation of the hallux (HP:0010051) | 2.05688781 |
| 86 | Spinal cord lesions (HP:0100561) | 2.05066216 |
| 87 | Syringomyelia (HP:0003396) | 2.05066216 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04756032 |
| 89 | Loss of speech (HP:0002371) | 2.02097026 |
| 90 | Mild short stature (HP:0003502) | 2.01587514 |
| 91 | Hallux valgus (HP:0001822) | 2.00649376 |
| 92 | Wide anterior fontanel (HP:0000260) | 1.99278726 |
| 93 | Round ear (HP:0100830) | 1.97376880 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 1.94934149 |
| 95 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93461186 |
| 96 | Ulnar bowing (HP:0003031) | 1.92880382 |
| 97 | Increased connective tissue (HP:0009025) | 1.91060733 |
| 98 | Hypoplasia of the iris (HP:0007676) | 1.90391469 |
| 99 | Decreased skull ossification (HP:0004331) | 1.90322861 |
| 100 | Venous abnormality (HP:0002624) | 1.90043532 |
| 101 | Camptodactyly of toe (HP:0001836) | 1.89540732 |
| 102 | Platyspondyly (HP:0000926) | 1.88424157 |
| 103 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88027463 |
| 104 | Emphysema (HP:0002097) | 1.87011461 |
| 105 | Venous insufficiency (HP:0005293) | 1.85419409 |
| 106 | Abnormality of skull ossification (HP:0002703) | 1.84832522 |
| 107 | Abnormality of the anterior chamber (HP:0000593) | 1.84364078 |
| 108 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.83272636 |
| 109 | Abnormality of the pericardium (HP:0001697) | 1.82842396 |
| 110 | Striae distensae (HP:0001065) | 1.82390478 |
| 111 | Poor head control (HP:0002421) | 1.82223149 |
| 112 | Asymmetric septal hypertrophy (HP:0001670) | 1.81673900 |
| 113 | Thoracolumbar scoliosis (HP:0002944) | 1.81585330 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.81504301 |
| 115 | Cellulitis (HP:0100658) | 1.81288429 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.81215830 |
| 117 | Congenital glaucoma (HP:0001087) | 1.80993224 |
| 118 | Myocardial infarction (HP:0001658) | 1.80333079 |
| 119 | Generalized amyotrophy (HP:0003700) | 1.78634587 |
| 120 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.78176236 |
| 121 | Hypoventilation (HP:0002791) | 1.77998287 |
| 122 | Mitral regurgitation (HP:0001653) | 1.77263245 |
| 123 | Absent frontal sinuses (HP:0002688) | 1.77011477 |
| 124 | Inguinal hernia (HP:0000023) | 1.75681211 |
| 125 | Flexion contracture of toe (HP:0005830) | 1.75610996 |
| 126 | Joint contractures involving the joints of the feet (HP:0100492) | 1.75610996 |
| 127 | Abnormality of macrophages (HP:0004311) | 1.73558291 |
| 128 | Achilles tendon contracture (HP:0001771) | 1.73510189 |
| 129 | Protruding ear (HP:0000411) | 1.71631333 |
| 130 | Basal ganglia calcification (HP:0002135) | 1.71208050 |
| 131 | Short nail (HP:0001799) | 1.71008120 |
| 132 | Abnormality of complement system (HP:0005339) | 1.69630417 |
| 133 | Cupped ribs (HP:0000887) | 1.69315468 |
| 134 | Aortic regurgitation (HP:0001659) | 1.69248974 |
| 135 | Radial bowing (HP:0002986) | 1.68808070 |
| 136 | Mesomelia (HP:0003027) | 1.68779608 |
| 137 | Morphological abnormality of the middle ear (HP:0008609) | 1.67799302 |
| 138 | Osteopenia (HP:0000938) | 1.66710504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.77820143 |
| 2 | DDR2 | 4.39990908 |
| 3 | ERN1 | 3.78004023 |
| 4 | RIPK4 | 3.06489982 |
| 5 | LATS2 | 3.05292077 |
| 6 | TTN | 2.87884380 |
| 7 | MAP3K14 | 2.79558253 |
| 8 | GRK7 | 2.77648076 |
| 9 | BLK | 2.76326589 |
| 10 | BMX | 2.68231154 |
| 11 | NME2 | 2.41239589 |
| 12 | TBK1 | 2.40697732 |
| 13 | PDGFRA | 2.38576920 |
| 14 | PIM2 | 2.36263132 |
| 15 | TRIB3 | 2.16833079 |
| 16 | JAK3 | 2.01331127 |
| 17 | MAP3K3 | 1.91665182 |
| 18 | EPHA3 | 1.88069899 |
| 19 | MST1R | 1.87747460 |
| 20 | TYK2 | 1.87400570 |
| 21 | PRPF4B | 1.87214870 |
| 22 | CDC42BPA | 1.84373343 |
| 23 | SIK1 | 1.80627549 |
| 24 | NEK9 | 1.77625751 |
| 25 | IKBKB | 1.72177072 |
| 26 | JAK1 | 1.70136229 |
| 27 | ABL2 | 1.69884681 |
| 28 | RPS6KA4 | 1.55217528 |
| 29 | EPHB2 | 1.49563742 |
| 30 | MYLK | 1.49444794 |
| 31 | ADRBK2 | 1.46720487 |
| 32 | TRPM7 | 1.46495618 |
| 33 | MOS | 1.33669139 |
| 34 | MAP3K13 | 1.32173860 |
| 35 | KIT | 1.30729081 |
| 36 | CLK1 | 1.29845228 |
| 37 | TIE1 | 1.25865287 |
| 38 | MAP2K3 | 1.23753164 |
| 39 | MET | 1.16292734 |
| 40 | ARAF | 1.10541554 |
| 41 | ERBB3 | 1.08837398 |
| 42 | IKBKE | 1.07621655 |
| 43 | PAK6 | 1.06566276 |
| 44 | PLK2 | 1.02351191 |
| 45 | STK3 | 0.97728363 |
| 46 | TESK1 | 0.93995329 |
| 47 | PDGFRB | 0.93353327 |
| 48 | ERBB4 | 0.91389903 |
| 49 | MAP3K11 | 0.90665044 |
| 50 | TAOK1 | 0.90440141 |
| 51 | LATS1 | 0.88042326 |
| 52 | PKN2 | 0.84415032 |
| 53 | RIPK1 | 0.82884784 |
| 54 | PRKD2 | 0.81404827 |
| 55 | PAK3 | 0.79538850 |
| 56 | CHUK | 0.79076995 |
| 57 | LRRK2 | 0.75314834 |
| 58 | PAK2 | 0.74879604 |
| 59 | HCK | 0.74073782 |
| 60 | TYRO3 | 0.72602969 |
| 61 | IRAK3 | 0.72151175 |
| 62 | CSK | 0.71232684 |
| 63 | PIM1 | 0.70306206 |
| 64 | KSR2 | 0.70145631 |
| 65 | BMPR2 | 0.69301940 |
| 66 | MARK3 | 0.68177175 |
| 67 | EIF2AK2 | 0.67939507 |
| 68 | IRAK2 | 0.67352250 |
| 69 | NTRK1 | 0.66914566 |
| 70 | FER | 0.66653500 |
| 71 | JAK2 | 0.65501614 |
| 72 | IRAK4 | 0.64874906 |
| 73 | DAPK3 | 0.64066075 |
| 74 | MAPK7 | 0.62720589 |
| 75 | FGR | 0.61451477 |
| 76 | INSR | 0.59976302 |
| 77 | MAP2K1 | 0.57509666 |
| 78 | PIK3CG | 0.57343675 |
| 79 | ABL1 | 0.57065055 |
| 80 | ZAP70 | 0.55231431 |
| 81 | LYN | 0.54006353 |
| 82 | PTK2 | 0.53966255 |
| 83 | GRK5 | 0.53579766 |
| 84 | MAP3K5 | 0.52632456 |
| 85 | GSK3A | 0.52625504 |
| 86 | MAPK4 | 0.51434901 |
| 87 | FGFR4 | 0.49732298 |
| 88 | TGFBR2 | 0.48812450 |
| 89 | STK4 | 0.48479988 |
| 90 | TXK | 0.48022420 |
| 91 | MAP3K10 | 0.47984356 |
| 92 | RPS6KA2 | 0.47654828 |
| 93 | ROCK2 | 0.47291310 |
| 94 | FLT3 | 0.47131714 |
| 95 | STK10 | 0.47071508 |
| 96 | HIPK2 | 0.46692623 |
| 97 | ROCK1 | 0.46531924 |
| 98 | PTK2B | 0.46208946 |
| 99 | MAP3K1 | 0.45574082 |
| 100 | FGFR3 | 0.45568183 |
| 101 | LCK | 0.45433057 |
| 102 | SCYL2 | 0.45217049 |
| 103 | CDK6 | 0.45210357 |
| 104 | PAK4 | 0.45027997 |
| 105 | ADRBK1 | 0.44997261 |
| 106 | DYRK3 | 0.44688209 |
| 107 | EPHB1 | 0.44411470 |
| 108 | FGFR1 | 0.44171996 |
| 109 | PKN1 | 0.43985585 |
| 110 | PIK3CA | 0.43518705 |
| 111 | PAK1 | 0.42395847 |
| 112 | RPS6KA6 | 0.41509317 |
| 113 | PRKCH | 0.40998782 |
| 114 | PRKCD | 0.40199134 |
| 115 | CDK15 | 0.39726092 |
| 116 | CDK14 | 0.38674077 |
| 117 | TEC | 0.37906269 |
| 118 | EGFR | 0.37262365 |
| 119 | MELK | 0.36910254 |
| 120 | RPS6KC1 | 0.36859446 |
| 121 | RPS6KL1 | 0.36859446 |
| 122 | CDK11A | 0.35369142 |
| 123 | LIMK1 | 0.35011339 |
| 124 | CDK18 | 0.34123679 |
| 125 | TGFBR1 | 0.33288506 |
| 126 | STK38 | 0.32925060 |
| 127 | TAOK2 | 0.32732717 |
| 128 | IGF1R | 0.32641818 |
| 129 | MATK | 0.32577187 |
| 130 | SRC | 0.32136500 |
| 131 | MAP3K6 | 0.32071958 |
| 132 | SIK3 | 0.31411305 |
| 133 | ICK | 0.31297046 |
| 134 | DYRK1B | 0.30478095 |
| 135 | MTOR | 0.30337227 |
| 136 | PTK6 | 0.30301622 |
| 137 | IRAK1 | 0.30228502 |
| 138 | YES1 | 0.29541375 |
| 139 | AKT3 | 0.25484327 |
| 140 | BRAF | 0.25013376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 3.57349234 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.24141151 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75064266 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.55212142 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.53072192 |
| 6 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.50146043 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.49132676 |
| 8 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.25421677 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22191681 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19207459 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.11314912 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99606494 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.97764608 |
| 14 | Salmonella infection_Homo sapiens_hsa05132 | 1.97221895 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95545400 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.91540886 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.91384418 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90872458 |
| 19 | Amoebiasis_Homo sapiens_hsa05146 | 1.89885739 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88745089 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.88093289 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.77812299 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.66329069 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55842489 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41143668 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40592368 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37801036 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37486803 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.36956717 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.36940307 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.36821453 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.36478130 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36214757 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.32279694 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27652553 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.23971505 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23576437 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.18230947 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.17984728 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.17130052 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09751930 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06843249 |
| 43 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.03992112 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00961787 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.94826088 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94131408 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93233633 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 0.92393784 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92332586 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90667748 |
| 51 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.88415535 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87487788 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85035617 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84525547 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84311049 |
| 56 | Melanoma_Homo sapiens_hsa05218 | 0.82572451 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.78481564 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77979749 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76781702 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76009760 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75562478 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73612984 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72493867 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70749990 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70582792 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67953680 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67889913 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65547286 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65303021 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64930358 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63123685 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62052820 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61104176 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59618164 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58223825 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.57965688 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57617261 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56810247 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56734060 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54487186 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54474758 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52377230 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51457080 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50390728 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49275325 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49204295 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49104500 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49060253 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49039486 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48897594 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.47630923 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47058447 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46872725 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.46313223 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45786651 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45645771 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42564888 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42158151 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.41749755 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.41452107 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38748267 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38589815 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38527512 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.36744702 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36427999 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34989873 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34254232 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33698803 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33482701 |
| 110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33389829 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33350526 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33343888 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32158018 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31582313 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31173037 |

